Revascularization Strategies in Patients with Diabetes and Acute Coronary Syndromes
暂无分享,去创建一个
[1] L. Thomas,et al. Diabetes and Incomplete Revascularisation in ST Elevation Myocardial Infarction. , 2020, Heart, lung & circulation.
[2] E. Barbato,et al. Coronary Artery Bypass Grafting or Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Diabetic Patients With Multivessel Disease , 2020, Circulation. Cardiovascular interventions.
[3] Xiaoxia Song,et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025 , 2020, Scientific Reports.
[4] P. Austin,et al. Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease. , 2020, Journal of the American College of Cardiology.
[5] P. Austin,et al. Revascularization Strategies for the Treatment of Multivessel Coronary Artery Disease in Patients With Diabetes Mellitus. , 2020, Circulation. Cardiovascular interventions.
[6] L. Thomas,et al. Cardiac mortality, diabetes mellitus, and multivessel disease in ST elevation myocardial infarction. , 2020, International journal of cardiology.
[7] G. Stone,et al. The Hybrid Coronary Approach for Optimal Revascularization: JACC Review Topic of the Week. , 2020, Journal of the American College of Cardiology.
[8] L. H. A. Salis,et al. Complete Revascularization with Multivessel PCI for Myocardial Infarction. , 2020, The New England journal of medicine.
[9] M. Farkouh,et al. Translating Scientific Evidence Into Clinical Practice: Closing the Loop. , 2019, The Canadian journal of cardiology.
[10] K. J. Miller,et al. Examining Coronary Revascularization Practice Patterns for Diabetics: Perceived Barriers, Facilitators, and Implications for Knowledge Translation. , 2019, The Canadian journal of cardiology.
[11] G. Bisleri,et al. Long-term outcome of total arterial myocardial revascularization versus conventional coronary artery by-pass in diabetic and non-diabetic patients: A propensity-match analysis. , 2019, Cardiovascular revascularization medicine : including molecular interventions.
[12] V. Fuster,et al. Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease. , 2019, Journal of the American College of Cardiology.
[13] P. Kolh,et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial , 2019, The Lancet.
[14] Xiantao Song,et al. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes , 2019, Cardiovascular Diabetology.
[15] Samin K. Sharma,et al. Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study. , 2019, Journal of the American College of Cardiology.
[16] F. Neumann,et al. 'Ten commandments' for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization. , 2019, European heart journal.
[17] Sidney C. Smith,et al. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project , 2018, Cardiovascular Diabetology.
[18] J. Puskas,et al. Hybrid coronary revascularization for the treatment of multivessel coronary artery disease. , 2018, Annals of cardiothoracic surgery.
[19] G. Angelini,et al. Radial‐Artery or Saphenous‐Vein Grafts in Coronary‐Artery Bypass Surgery , 2018, The New England journal of medicine.
[20] V. Thourani,et al. Aortic clamping strategy and postoperative stroke , 2018, The Journal of thoracic and cardiovascular surgery.
[21] V. Fuster,et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data , 2018, The Lancet.
[22] Deepak L. Bhatt,et al. Do We Need a Trial of DES Versus CABG Surgery in Diabetic Patients With ACS? , 2017, Journal of the American College of Cardiology.
[23] S. Verma,et al. Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes. , 2017, Journal of the American College of Cardiology.
[24] M. Domanski,et al. Type 1 Diabetes, Coronary Disease Complexity, and Optimal Revascularization Strategy. , 2017, Journal of the American College of Cardiology.
[25] P. Serruys,et al. Comparison of Outcome of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Non-ST-Elevation Acute Coronary Syndrome. , 2017, The American journal of cardiology.
[26] I. Elgendy,et al. Early Invasive Strategy and In‐Hospital Survival Among Diabetics With Non‐ST‐Elevation Acute Coronary Syndromes: A Contemporary National Insight , 2017, Journal of the American Heart Association.
[27] J. Ottervanger,et al. Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction , 2016, Open Heart.
[28] G. Lemesle,et al. A systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction. , 2016, International journal of cardiology.
[29] Shengshou Hu,et al. One-stop hybrid coronary revascularization versus off-pump coronary artery bypass in patients with diabetes mellitus. , 2016, The Journal of thoracic and cardiovascular surgery.
[30] I. Elgendy,et al. A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients With Acute ST Elevation Myocardial Infarction and Multi Vessel Disease. , 2016, Journal of interventional cardiology.
[31] A. Pandey,et al. Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non–ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry–Get with the Guideli , 2016, Circulation. Cardiovascular quality and outcomes.
[32] P. Serruys,et al. Balancing idealism with realism to safeguard the welfare of patients: The importance of Heart Team led decision-making in patients with complex coronary artery disease , 2016, Indian heart journal.
[33] T. Vassiliades,et al. Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study. , 2013, Journal of the American College of Cardiology.
[34] S. Bangalore,et al. Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes. , 2015, The New England journal of medicine.
[35] M. Desai,et al. Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease. , 2015, American heart journal.
[36] E. Ohman,et al. Surgical Versus Percutaneous Coronary Revascularization for Multivessel Disease in Diabetic Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome: Analysis From the Acute Catheterization and Early Intervention Triage Strategy Trial , 2015, Circulation. Cardiovascular interventions.
[37] A. Yeung,et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. , 2015, The New England journal of medicine.
[38] C. Terkelsen,et al. Underuse of an invasive strategy for patients with diabetes with acute coronary syndrome: a nationwide study , 2015, Open Heart.
[39] T. Vassiliades,et al. Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus. , 2014, American heart journal.
[40] J. Rutledge,et al. Coronary artery revascularization in patients with diabetes mellitus. , 2013, Circulation.
[41] A. Pereira,et al. Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial. , 2013, American heart journal.
[42] M. Mack,et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[43] M. Shishehbor,et al. Strategies for multivessel revascularization in patients with diabetes , 2013 .
[44] L. Räber,et al. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. , 2012, JAMA.
[45] Helmut Baumgartner,et al. ESC / EACTS Guidelines on myocardial revascularization , 2014 .
[46] Lawrence A Leiter,et al. Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes. , 2011, American heart journal.
[47] P. Serruys,et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. , 2010, Journal of the American College of Cardiology.
[48] G. Angelini,et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. , 2010, Journal of the American College of Cardiology.
[49] Maria Mori Brooks,et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.
[50] Christopher P Cannon,et al. Diabetes and mortality following acute coronary syndromes. , 2007, JAMA.
[51] B. Gersh. Clinical Judgment and Treatment Options in Stable Multivessel Coronary Artery Disease: Results From the One-Year Follow-Up of the MASS II (Medicine, Angioplasty, or Surgery Study II) , 2007 .
[52] B. Gersh,et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. , 2007, Circulation.
[53] J. Krieger,et al. Clinical judgment and treatment options in stable multivessel coronary artery disease: results from the one-year follow-up of the MASS II (Medicine, Angioplasty, or Surgery Study II). , 2006, Journal of the American College of Cardiology.
[54] O. Aslan,et al. Are complex coronary lesions more frequent in patients with diabetes mellitus? , 2006, The Canadian journal of cardiology.
[55] J. Núñez,et al. [Invasive strategy in patients with advanced diabetes and non-ST-segment elevation acute coronary syndrome. Angiographic findings and clinical follow-up. PREDICAR study results]. , 2006, Revista espanola de cardiologia.
[56] Patrick W Serruys,et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. , 2005, Journal of the American College of Cardiology.
[57] J. Beckman,et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.
[58] Volkmar Falk,et al. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. , 2003, The Annals of thoracic surgery.
[59] M. di Mauro,et al. Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. , 2003, The Journal of thoracic and cardiovascular surgery.
[60] P. Serruys,et al. Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients , 2001 .
[61] P. Serruys,et al. Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients: Insights From the Arterial Revascularization Therapy Study (ARTS) Trial , 2001, Circulation.
[62] A. Abacı,et al. Effect of diabetes mellitus on formation of coronary collateral vessels. , 1999, Circulation.
[63] Robert L. Frye,et al. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.